Susquehanna International Group (Ireland)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-52,697
Closed -$2.03M 129
2024
Q2
$2.03M Sell
52,697
-4,691
-8% -$197K 0.51% 25
2024
Q1
$2.46M Buy
+57,388
New +$2.37M 0.58% 21
2023
Q4
Sell
-12,009
Closed -$435K 69
2023
Q3
$435K Sell
12,009
-37,227
-76% -$1.32M 0.1% 44
2023
Q2
$1.75M Buy
+49,236
New +$1.77M 1.41% 16

Other funds holding GSK

Susquehanna International Group (Ireland)'s GSK Position: Q3 2024 in Review

Susquehanna International Group (Ireland) sold out of GSK (GSK) in Q3 2024, closing a stake of 52,697 shares — an estimated $2.03M sold.

Susquehanna International Group (Ireland) first reported a position in GSK in Q2 2023 and held it in 4 quarters. The position peaked at $2.46M in Q1 2024. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Susquehanna International Group (Ireland) reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 52,697 GSK shares in Q3 2024, an estimated $2.03M.
  • Susquehanna International Group (Ireland) first reported a position in GSK in Q2 2023 and held it in 4 quarters.
  • Susquehanna International Group (Ireland)'s GSK position peaked at $2.46M in Q1 2024.
  • 900 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q3 2024, filed 14 Nov 2024.